EMA Human Scientific Committees' Working Parties with Patients' and Consumers' Organisations (PCWP) and Healthcare Professionals' Organisations (HCPWP) joint meeting

• Date:
  Tuesday, 27 June 2017, All day
• Location:
  European Medicines Agency, Amsterdam, the Netherlands

This is a joint meeting with representatives from patients', consumers' and healthcare professionals' organisations. On June 27, EUnetHTA speakers will join the meeting to present on their activities and discuss areas of collaboration with patients and healthcare professionals; on June 28 there will be a presentation on the European Commission's report on the shortcomings of product information followed by a discussion on the implementation of the report's recommendations. Also during the two-day meeting, participants will learn about the HMA/EMA Taskforce on availability of authorised medicines and discuss their involvement in the Pharmacovigilance additional monitoring impact analysis; other topics for discussion include a proposal for revision of PCWP/HCPWP mandates and rules of procedure, the principles and practical considerations for streamlining the process for re-assessment of eligibility status, and the drafting process for a joint 2018/19 Work Plan.

Documents

Agenda - EMA Human Scientific Committees' Working Parties with Patients’ and Consumers’ Organisations (PCWP) and Healthcare Professionals’ Organisations (HCPWP) joint meeting (27 June 2017)

AdoptedReference Number: EMA/213892/2017

List of participants - EMA Human Scientific Committees' Working Parties with Patients’ and Consumers’ Organisations (PCWP) and Healthcare Professionals’ Organisations (HCPWP) joint meeting (27 June 2017)

Reference Number: EMA/258524/2017

Minutes - EMA Human Scientific Committees' Working Parties with Patients’ and Consumers’ Organisations (PCWP) and Healthcare Professionals’ Organisations (HCPWP) joint meeting (27 June 2017)

Reference Number: EMA/355452/2017

Presentation - Conditional marketing authorisation - Report on ten years of experience at the EMA (Zigmars Sebris, EMA)

Presentation - Patient and Healthcare Professional Involvement in EUnetHTA Activities (Michelle Mujoomdar)

Presentation - HMA/EMA Taskforce on availability of authorised medicines (Brendan Cuddy, EMA)

Presentation - PRIME: One year experience and highlights from 19 May stakeholder meeting (Zahra Hanaizi, Jordi Llinares, EMA)

Presentation - Survey to estimate patients and HCP awareness of the additional monitoring concept (Justina Januskiene, EMA)

Presentation - EMA framework of collaboration with academia (Monica Ensini, EMA)

Presentation - HCPWP/PCWP feedback from CHMP (Fà¡tima Ventura, EMA)

Presentation - Committee for Advanced Therapies (CAT) update (Kieran Breen)

Presentation - Committee on Herbal Medicinal Products (HMPC) update (Steinar Madsen)

Presentation - Pharmacovigilance Risk Assessment Committee (PRAC) update (Raymond Anderson)

Presentation - Patient Access Partnership (Stanimir Hasardzhiev, PACT)

Presentation - The Commission report on SmPC and package leaflet for medicinal products for human use (K.Kurgonaite)